Lin Tai-An 4
4 · SpringWorks Therapeutics, Inc. · Filed Oct 4, 2023
Insider Transaction Report
Form 4
Lin Tai-An
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-10-02+75,000→ 75,000 totalExercise: $22.80Exp: 2033-10-02→ Common Stock (75,000 underlying) - Award
Common Stock
2023-10-02+24,000→ 24,000 total
Footnotes (2)
- [F1]This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty three percent (33%) to vest on October 2, 2024, another thirty three percent (33%) to vest on October 2, 2025 and the remaining thirty four percent (34%) to vest on October 2, 2026, such that the restricted stock awards are fully vested on October 2, 2026, subject to continued service to the Issuer by the Reporting Person.
- [F2]Twenty-five percent (25%) of this option shall vest and become exercisable on October 2, 2024, with the remaining seventy-five percent (75%) to vest in thirty-six (36) equal monthly installments thereafter, subject to continued service to the Issuer by the Reporting Person.